Chromocell Therapeutics Corp (CHRO)
1.47
-0.03
(-2.00%)
USD |
NYAM |
Jun 06, 15:18
Chromocell Therapeutics Total Liabilities (Quarterly): 5.927M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.927M |
| June 30, 2023 | 4.983M |
| March 31, 2023 | 4.450M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.762M |
| September 30, 2022 | 3.181M |
| December 31, 2021 | 3.680M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.181M
Minimum
Sep 2022
5.927M
Maximum
Sep 2023
4.330M
Average
4.106M
Median
Total Liabilities (Quarterly) Benchmarks
| iBio Inc | 25.29M |
| Lixte Biotechnology Holdings Inc | 0.4628M |
| PDS Biotechnology Corp | 31.82M |
| Syros Pharmaceuticals Inc | 119.67M |
| Nutriband Inc | 1.791M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0228M |
| Shareholders Equity (Quarterly) | -5.905M |